Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Timolol eye-drops can cause hair loss.

HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Human hair is a significant sample for various tests in clinical, nutritional, archaeological, and forensic studies.

The document explains various skin conditions and their treatments.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

The paper concludes that understanding melanocyte development can help in insights into skin diseases and melanoma diversity.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.